Core One Labs (COOL.C) announced they have reached a definitive share purchase agreement which will see it acquire all outstanding share capital of Akome Biotech. Akome Biotech’s goal is…
Psychedelics
Pharmadrug’s (BUZZ.C) subsidiary Sairiyo Therapeutics received their orphan drug designation (ODD) for dimethyltryptamine (DMT) from the United States Food and Drug Administration (FDA) for the prevention of ischemia-reperfusion injury…
Delic Holdings (DELC.C) announced that their acquisition target, Complex Biotech Discovery Ventures (CBDV), has hired Dr. Eric Janusson as their Lead Chemist. Dr. Eric Janusson is an analytical organometallic…
Core One Labs (COOL.C) announced they have entered into a letter of intent (LOI) with Lobe Sciences (LOBE.C) to explore the formation of a joint venture (JV) involving the…
Nova Mentis (NOVA.C) is on a mission to incorporate psychedelics in treating chronic inflammatory conditions like autism spectrum disorder (ASD), fragile X syndrome (FXS), epilepsy, traumatic brain injury, multiple…
“Psilocybin offers a potential solution to manage moderate to severe cases of TBI,” stated RVV, “Psilocybin has the potential with its neuroreparative effect to improve loss of cognitive function…
Halo Collective (HALO.E) and Red Light Holland (TRIP.C) filed articles of incorporation with the Oregon Secretary of State to form a 50/50 joint venture called Red Light Oregon today,…
PsyBio Therapeutics (PSYB.V) have amended their agreement with Miami University in Oxford, Ohio to extend and expand their collaborative efforts. The amended agreement would increase the research efforts of…
Cybin (CYBN.NE) announced that they will be using Alcohol Use Disorder (AUD) as the initial target indication for their proprietary psychedelic molecule, CYB003. “AUD is a chronic relapsing brain…
Sexy ass CPG products The psychedelics space is filled with outdated healthcare style branding reminiscent of hospital waiting rooms. It’s also filled with wildly futuristic Matrix bullshit. NeonMind Biosciences…